Cortechs.ai | Dr. James Brewer on NeuroQuant

Dr. James Brewer on NeuroQuant

DrJamesBrewer.jpgDr. Brewer is the Chief Medical Advisor for Cortechs.ai and was the first physician to incorporate NeuroQuant® into clinical practice. He assisted in the design of the NeuroQuant reports and in the studies that led to NeuroQuant’s FDA clearance in 2006.

In 2004, he joined the faculty of the University of California, San Diego, where he has a joint appointment in Radiology and Neurosciences. Dr. Brewer sees patients at the University of California, San Diego and the Veterans Affairs Hospital in La Jolla.

Dr. Brewer’s primary research interest is human memory. He uses functional and structural magnetic resonance imaging (MRI) to study memory processes in volunteers with healthy memory and in patients with memory impairment, such as cases caused by Alzheimer’s disease (AD).

Dr. Brewer received his graduate and medical training at Stanford University and his neurology residency training at Johns Hopkins University.

In the webinar below, Dr. Brewer shares his experience using NeuroQuant, and gives an overview how NeuroQuant can help physicians improve their assessment of neurodegenerative disease, such as Alzheimer’s disease, multiple sclerosis, epilepsy, as well brain trauma and brain development.

More Resources

05/04/2025

Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

Discover how the latest NeuroQuant MS update offers a clearer, more intuitive way to track lesion changes and understand disease progression over time.

05/02/2025

4 Reasons Why Over 1500 Medical Centers Worldwide Trust Cortechs.ai

Trusted by 1500+ medical centers, Cortechs.ai delivers AI-powered imaging tools that enhance diagnostic accuracy and streamline workflows.

04/22/2025

Cortechs.ai Receives Health Canada Approval to Expand Sales of AI-Powered Imaging Solutions in North America

Cortechs.ai receives Health Canada approval to expand its AI imaging solutions into Canada, advancing diagnostic precision and patient care.

04/02/2025

Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series

Brain volumetrics play a pivotal role in understanding pediatric neurological development. Explore how NeuroQuant® enhances neuroimaging from ages 3 to 100.

03/31/2025

How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology

What if head CT assessment could be even faster and more accurate? Subtraction maps allow for improved detection and visualization of subtle interval changes.

03/27/2025

Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

We are pleased to announce a strategic partnership with Kryptonite Solutions to distribute our innovative portfolio across India.
Scroll to Top